Skip Navigation


JAC Advance Access originally published online on February 4, 2009
Journal of Antimicrobial Chemotherapy 2009 63(4):728-732; doi:10.1093/jac/dkp007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
63/4/728    most recent
dkp007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gillham, M. I.
Right arrow Articles by Foweraker, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillham, M. I.
Right arrow Articles by Foweraker, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis

M. I. Gillham1, S. Sundaram2, C. R. Laughton1, C. S. Haworth2, D. Bilton3 and J. E. Foweraker1,*

1 Department of Microbiology, Papworth Hospital, Cambridge CB23 3RE, UK 2 Lung Defence Unit, Papworth Hospital, Cambridge CB23 3RE, UK 3 Department of Respiratory Medicine, Royal Brompton Hospital, London SW3 6NP, UK

Received 24 October 2008; returned 23 November 2008; revised 2 January 2009; accepted 4 January 2009

* Corresponding author. Tel: +44-1480-364305; Fax: +44-1480-364780; E-mail: juliet.foweraker{at}papworth.nhs.uk

Objectives: To investigate variability in colony morphology and antibiotic susceptibility in populations of Pseudomonas aeruginosa from sputa of patients with bronchiectasis without cystic fibrosis (CF) compared with P. aeruginosa isolated from patients with CF, and from other infections as controls.

Methods: P. aeruginosa was cultured from 31 patients with non-CF bronchiectasis, 24 with CF, 7 ventilated patients and 9 skin swabs. Four colonies of each morphotype of P. aeruginosa were tested for susceptibility to 12 antibiotics by disc diffusion. The variability in susceptibility between the isolates in each patient’s population of P. aeruginosa was investigated.

Results: The classic morphotype of P. aeruginosa was cultured from control samples with an average variation in zone size of 2 mm (range 0–4 mm) for the four colonies tested. Non-CF bronchiectasis sputa contained 1–3 colonial morphotypes of P. aeruginosa; the average difference between the largest and smallest zone sizes found in all examples of the morphotypes present in each sample varied from 3 mm (1–9 mm) for colistin to 8 mm (0–24 mm) for piperacillin/tazobactam. CF sputa contained 2–6 morphotypes of P. aeruginosa with a wider variation of susceptibility. There was variation between bacteria of the same morphotype from non-CF bronchiectasis and CF sputa.

Conclusions: Phenotypic variation in colonial form and antibiotic susceptibility is not unique to chronic infection in CF but is also found in non-CF bronchiectasis. This questions the use of current susceptibility testing methods for the complex populations of bacteria found in chronic lung infection.

Keywords: P. aeruginosa , morphotypes , disc diffusion , cystic fibrosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.